NCT03643523

Brief Summary

Colorectal surgery has traditionally been associated with significant morbidity and prolonged hospital stay. Overall complication rates have been reported to be 26-35%. Infectious complications, in particular, represent a major cause of morbidity and mortality after colorectal surgery. Postoperative intra-abdominal infections after colorectal surgery are mainly due to anastomotic leakage. They occur in 5 to 15% of patients and carry a short term mortality of around 20%. They also have a major impact on the outcome of surgery as they prolong in hospital stay, increase treatment costs and worsen long-term survival in cancer patients. If diagnosed early, they can be treated effectively and their impact on surgery outcome is thus minimised. There is a growing interest to find a biological marker useful for early detection of anastomotic leak; such a marker could play a pivotal role in the modern fast-track multimodal protocols, allowing safe and early discharge of patients after colorectal surgery. Although C reactive protein (CRP) and procalcitonin (PCT) have been proposed as predictors for adverse outcomes in colorectal surgery, they both display the critical limitations of slow kinetics. Conversely, serum albumin (ALB) is a maintenance protein that is rapidly down regulated by inflammatory signals. There some studies about the use of postoperative ALB drop as a marker of predictor for clinical outcome. These studies are either retrospective or mix patients with different types of surgical procedures performed. This study aimed to test the hypotheses that early postoperative albumin drop can predict anastomotic leaks and also can predict postoperative infectious complications earlier than other biological markers.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 22, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

January 15, 2019

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2018

Enrollment Period

17 days

First QC Date

August 21, 2018

Last Update Submit

August 21, 2018

Conditions

Keywords

anastomitic leak, infectious complications, colorectal surgery

Outcome Measures

Primary Outcomes (1)

  • Determination of serum albumine levels

    One year

Study Arms (1)

ALbumin level

Detection of serum albumin levels in postoperatory of colorectal surgery

Diagnostic Test: Albumine detection

Interventions

Albumine detectionDIAGNOSTIC_TEST

Control of serum albumine levels in postoperatori of colorectal surgery

ALbumin level

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated on scheludec colorectal surgery with primary anastomosis

You may qualify if:

  • Patients older than 18 years
  • Patients undergoing major colorectal surgery (expected to last 2 hours or more)
  • Performing primary anastomosis
  • Scheluded surgery
  • Patients who give their written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 21, 2018

First Posted

August 22, 2018

Study Start

January 15, 2019

Primary Completion

February 1, 2019

Study Completion

December 31, 2019

Last Updated

August 22, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share